Positive Brexu-Cel Findings Raise Questions of Treatment Sequencing in B-ALL
Gregory W. Roloff, MD, indicates that brexucabtagene autoleucel did not yield significant positive findings in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who were MRD positive.